Skip to main content
. 2020 Sep 30;17(17):2773–2789. doi: 10.7150/ijms.43161

Figure 6.

Figure 6

Effect of HCK expression in the survival outcomes of breast cancer patients. A: (1) and (2): Representative positive HCK immunohistochemical staining of metastatic tumor in chest wall. (1): ×200 magnification; (2): ×400 magnification. (3) and (4): Representative positive HCK immunohistochemical staining of metastatic tumor in liver. (3): ×200 magnification; (4): ×400 magnification. (5) and (6): Representative positive HCK immunohistochemical staining results of metastatic tumor in lung. (5): ×200 magnification; (6): ×400 magnification. (7): The rate of HCK expression in metastatic tumor was significantly higher than primary tumor (P=0.028). B: DFS survival curve based on HCK expression in the overall population. C: OS survival curve based on HCK expression in the overall population. D: DFS survival curve in luminal A type patients based on HCK expression. E: OS survival curve in luminal A type patients based on HCK expression. F: DFS survival curve in luminal B type patients based on HCK expression. G: OS survival curve in luminal B type patients based on HCK expression.